Posts

Innovative research aims to improve wound healing and cancer therapy

Innovative research aims to improve wound healing and c...

Oct 28, 2023

Jun.-Prof. Dr. Priscilla Briquez, junior professor at the Department of General ...

Team synthesizes a new polyoxometalate-based metal-organic complex

Team synthesizes a new polyoxometalate-based metal-orga...

Oct 28, 2023

A research team has synthesized a new polyoxometalate-based metal-organic comple...

Engineers from the UMA develop more accessible and versatile next-gen “digital twins”

Engineers from the UMA develop more accessible and vers...

Oct 28, 2023

The next-gen “digital twins” are created at the University of Malaga. Three engi...

Belgium Considers Short-Term Prohibition of Novo’s Ozempic Weight Loss Drug

Belgium Considers Short-Term Prohibition of Novo’s Ozem...

Oct 27, 2023

Belgium is mulling over a temporary ban on the utilization of Novo Nordisk’s Oze...

AstraZeneca’s Self-Administered Flu Vaccine Inches Closer to FDA Green Light

AstraZeneca’s Self-Administered Flu Vaccine Inches Clos...

Oct 27, 2023

FluMist, AstraZeneca’s nasal spray influenza vaccine, has been on the market for...

EnginZyme Utilizes Biocatalysis to Manufacture Essentia...

Oct 27, 2023

EnginZyme AB, a cutting-edge technology company specializing in enzymatic bioman...

ISN-001 by Anterogen for Burns: Likelihood of Approval

Oct 27, 2023

ISN-001 is under clinical development by Anterogen and currently in Phase II for...

Selinexor by Karyopharm Therapeutics for Wilms’ Tumor (...

Oct 27, 2023

Selinexor is under clinical development by Karyopharm Therapeutics and currently...

Itacitinib adipate by Incyte for Cytokine Release Syndr...

Oct 27, 2023

Itacitinib adipate is under clinical development by Incyte and currently in Phas...

Selinexor by Karyopharm Therapeutics for Atypical Terat...

Oct 27, 2023

Selinexor is under clinical development by Karyopharm Therapeutics and currently...

Denifanstat by Sagimet Biosciences for Breast Cancer: L...

Oct 27, 2023

Denifanstat is under clinical development by Sagimet Biosciences and currently i...

Sotigalimab by Pyxis Oncology for Anaplastic Astrocytom...

Oct 27, 2023

Sotigalimab is under clinical development by Pyxis Oncology and currently in Pha...

Sotigalimab by Pyxis Oncology for Astrocytoma: Likeliho...

Oct 27, 2023

Sotigalimab is under clinical development by Pyxis Oncology and currently in Pha...

Sotigalimab by Pyxis Oncology for Glioblastoma Multifor...

Oct 27, 2023

Sotigalimab is under clinical development by Pyxis Oncology and currently in Pha...

Sotigalimab by Pyxis Oncology for Glioma: Likelihood of...

Oct 27, 2023

Sotigalimab is under clinical development by Pyxis Oncology and currently in Pha...

Sotigalimab by Pyxis Oncology for Esophageal Cancer: Li...

Oct 27, 2023

Sotigalimab is under clinical development by Pyxis Oncology and currently in Pha...